3 Dividend Growth Stocks to Buy Hand Over Fist in August
Dividend growth investing is an excellent strategy for any long-term investor. It involves buying and holding companies that pay and raise their dividends year after year. Investors benefit from dividends; you can reinvest them to buy more shares or pay living expenses. Additionally, companies must grow and responsibly manage their money to afford an ever-increasing obligation like a growing Dividend. It's a back-door litmus test for high-quality stocks.
This month, three stellar dividend growth stocks caught my eye in the healthcare sector. Take a look at what makes them so special and why they are table-pounding buys this month.
Grace Groner is one of my favorite investing stories. In 1935, she bought three shares of Abbott Laboratories (NYSE: ABT) as an employee. After living an ordinary life, she eventually died a multimillionaire from all the dividends and gains her investment accumulated throughout her lifetime. Nearly a century later, Abbott Labs remains a stalwart in healthcare. The company sells consumer health products, testing equipment, medical devices, and branded generic pharmaceuticals. Abbott is a global company with over $40 billion in annual sales.
Source Fool.com
Abbott Laboratories Stock
With 20 Buy predictions and not the single Sell prediction the community is currently very high on Abbott Laboratories.
As a result the target price of 115 € shows a slightly positive potential of 14.63% compared to the current price of 100.32 € for Abbott Laboratories.
